Northern Trust Corp Seres Therapeutics, Inc. Transaction History

Northern Trust Corp

$709 Billion
Q2 2025

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$0.64 - $0.91 $24,883 - $35,381	38,881 Added 14.8%	301,564 $211,000
Q4 2024 Feb 14, 2025	BUY	$0.55 - $0.98 $24,453 - $43,571	44,461 Added 20.37%	262,683 $218,000
Q3 2024 Nov 13, 2024	SELL	$0.7 - $1.48 $352,475 - $745,233	-503,536 Reduced 69.77%	218,222 $207,000
Q2 2024 Aug 14, 2024	SELL	$0.56 - $1.19 $35,243 - $74,892	-62,935 Reduced 8.02%	721,758 $519,000
Q1 2024 May 14, 2024	BUY	$0.75 - $1.56 $10,561 - $21,967	14,082 Added 1.83%	784,693 $604,000
Q4 2023 Feb 13, 2024	SELL	$0.93 - $2.15 $141,406 - $326,907	-152,050 Reduced 16.48%	770,611 $1.08 Million
Q3 2023 Nov 13, 2023	SELL	$2.33 - $5.07 $5,829 - $12,685	-2,502 Reduced 0.27%	922,661 $2.2 Million
Q2 2023 Aug 11, 2023	BUY	$4.67 - $6.55 $861,563 - $1.21 Million	184,489 Added 24.91%	925,163 $4.43 Million
Q1 2023 May 15, 2023	BUY	$4.95 - $6.09 $50,608 - $62,264	10,224 Added 1.4%	740,674 $4.2 Million
Q4 2022 Feb 13, 2023	SELL	$5.09 - $9.05 $20,517 - $36,480	-4,031 Reduced 0.55%	730,450 $4.09 Million
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $201,855 - $415,245	57,673 Added 8.52%	734,481 $4.72 Million
Q2 2022 Aug 12, 2022	SELL	$2.7 - $7.62 $64,654 - $182,468	-23,946 Reduced 3.42%	676,808 $2.32 Million
Q1 2022 May 13, 2022	SELL	$6.3 - $8.84 $235,626 - $330,624	-37,401 Reduced 5.07%	700,754 $4.99 Million
Q4 2021 Feb 08, 2022	BUY	$6.02 - $11.43 $341,213 - $647,852	56,680 Added 8.32%	738,155 $6.15 Million
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $183,630 - $760,083	-33,632 Reduced 4.7%	681,475 $4.74 Million
Q2 2021 Aug 13, 2021	BUY	$18.46 - $24.36 $1.34 Million - $1.77 Million	72,501 Added 11.28%	715,107 $17.1 Million
Q1 2021 May 12, 2021	SELL	$17.66 - $28.92 $754,276 - $1.24 Million	-42,711 Reduced 6.23%	642,606 $13.2 Million
Q4 2020 Feb 11, 2021	BUY	$23.25 - $37.73 $748,185 - $1.21 Million	32,180 Added 4.93%	685,317 $16.8 Million
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $374,190 - $2.88 Million	100,051 Added 18.09%	653,137 $18.5 Million
Q2 2020 Aug 14, 2020	BUY	$3.04 - $6.2 $254,177 - $518,388	83,611 Added 17.81%	553,086 $2.63 Million
Q1 2020 May 14, 2020	BUY	$2.64 - $3.82 $24,713 - $35,759	9,361 Added 2.03%	469,475 $1.68 Million
Q4 2019 Feb 14, 2020	SELL	$2.99 - $4.42 $45,749 - $67,630	-15,301 Reduced 3.22%	460,114 $1.59 Million
Q3 2019 Nov 13, 2019	BUY	$2.29 - $4.16 $488,104 - $886,687	213,146 Added 81.27%	475,415 $1.91 Million
Q2 2019 Aug 13, 2019	BUY	$2.28 - $7.35 $24,106 - $77,711	10,573 Added 4.2%	262,269 $844,000
Q1 2019 May 13, 2019	BUY	$4.83 - $7.21 $9,819 - $14,657	2,033 Added 0.81%	251,696 $1.73 Million
Q4 2018 Feb 12, 2019	SELL	$4.52 - $8.88 $8,027 - $15,770	-1,776 Reduced 0.71%	249,663 $1.13 Million
Q3 2018 Nov 14, 2018	BUY	$7.33 - $9.23 $37,595 - $47,340	5,129 Added 2.08%	251,439 $1.91 Million
Q2 2018 Sep 18, 2018	SELL	$6.91 - $9.55 $17,993 - $24,868	-2,604 Reduced 1.05%	246,310 $2.12 Million
Q2 2018 Aug 14, 2018	BUY	$6.91 - $9.55 $114,878 - $158,768	16,625 Added 7.16%	248,914 $2.14 Million
Q1 2018 May 09, 2018	SELL	$7.34 - $11.16 $1,710 - $2,600	-233 Reduced 0.1%	232,289 $1.71 Million
Q4 2017 Feb 14, 2018	SELL	$9.15 - $12.64 $45,493 - $62,846	-4,972 Reduced 2.09%	232,522 $2.36 Million
Q3 2017 Nov 13, 2017	BUY	$12.81 - $16.85 $3.04 Million - $4 Million	237,494	237,494 $3.81 Million

Others Institutions Holding MCRB

# of Institutions

Shares Held

1.79M

Call Options Held

Put Options Held

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $1.92B
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account